Stanford University
Showing 6,701-6,800 of 13,143 Results
-
Jonathan T.C. Liu, PhD
Professor of Pathology and Professor, by courtesy, of Bioengineering
Current Research and Scholarly InterestsBiomedical optics
In vivo microscopy
Slide-free pathology
Three-dimensional microscopy
3D pathology
Optical biopsy
Image-guided surgery
Early detection
Artificial intelligence
Machine learning
Deep learning
Computational analysis
Computational pathology
Virtual staining
Molecular imaging -
Juliana Liu, MSN, RN, ANP-C
Affiliate, CVI/Vera Moulton Wall Center
BioJuliana Liu, MSN, RN, ANP-C is the Program Manager and Nurse Practitioner for the Adult Pulmonary Hypertension Service at Stanford. She received her Adult Nurse Practitioner (ANP) degree from the University of California, San Francisco School of Nursing. She has a BA in History from Pomona College. Juliana Liu has worked in the Pulmonary Hypertension field since 2002, and has presented at numerous nursing and patient conferences in the US and abroad. She has also served as member and chair on several committees of the Pulmonary Hypertension Association.
-
Katherine Liu
MD Student, expected graduation Spring 2029
Ph.D. Student in Bioengineering, admitted Autumn 2026
MSTP StudentCurrent Research and Scholarly InterestsSignal and image processing of neural dynamics under various brain states
-
Lili Liu
Postdoctoral Scholar, Epidemiology
BioLili (Larry) Liu, PhD, is a postdoctoral fellow in the Department of Epidemiology and Population Health at Stanford University. Dr. Liu is an integrative epidemiologist whose research is unified by a consistent methodological approach rather than a single disease area. Across his master’s, doctoral, and postdoctoral training, he has repeatedly developed or operationalized epidemiologic frameworks and analytic programs and applied them to important public health questions spanning rare diseases, chronic disease, cancer, mortality, microbiome, and women’s health. His work brings together molecular biomarkers, large-scale population cohorts, and real-world health data to generate coherent, hypothesis-driven research on how genetic variation, lifestyle, pharmacologic factors, and early-life exposures shape inflammation, biological aging, and chronic disease risk across the life course.
During his master’s training at Peking University, Dr. Liu developed expertise in literature synthesis, national claims-based study, rare disease burden estimation, patient-centered health information research, cohort-based analysis, and vaccine effectiveness evaluation. He helped build and apply claims-based analytic algorithms to estimate incidence and prevalence for multiple rare diseases in China, led first-author studies on online health information and patient information needs in rare disease populations, and established an analytic framework for CHARLS-based cohort studies that supported multiple downstream projects. During his PhD training at Vanderbilt University, he expanded into population genetics, molecular and cancer epidemiology, mortality and health disparities research, gut microbiome, and pooled multi-study analyses. His doctoral work included a multi-ancestry GWAS of urinary prostaglandin E2 metabolite (PGE-M), development of PGE-M-derived dietary and lifestyle scores, and Mendelian randomization analyses linking lipid-related pathways to colorectal cancer risk. He also led several first-author studies in the Southern Community Cohort Study on poverty, sitting time, physical activity, walking and mortality, and alcohol intake and the gut microbiome, several of which received substantial public health and media attention.
At Stanford, Dr. Liu has developed an independent research program centered on women’s health and life-course epidemiology using U.S. national claims data. He has built large nationwide pregnancy and mother-baby cohorts from MarketScan to study adverse obstetric outcomes, long-term cardiometabolic and hepatic outcomes, and early-onset cancer risk. His first corresponding-author paper at Stanford examined gestational diabetes in relation to subsequent type 2 diabetes and metabolic dysfunction-associated steatotic liver disease, and his ongoing work extends this framework to cardiovascular, kidney, metabolic, and reproductive health outcomes, including PCOS and endometriosis. He also received a Stanford MCHRI fellowship grant to study prenatal and early-life antibiotic exposure in relation to pediatric inflammatory bowel disease and celiac disease. In parallel, his collaborative work includes placental and maternal-fetal research on extracellular vesicles and angiogenic signaling.
Methodologically, Dr. Liu works at the interface of causal inference, pharmacoepidemiology, molecular epidemiology, and scalable real-world data science, using reproducible analytic pipelines in R, Python, SQL, and high-performance computing environments. Across all stages of his training, the central theme of his work has been to build scalable analytic infrastructure and apply it to high-impact epidemiologic questions with broad public health relevance, with the overarching goal of translating rigorous population science into actionable strategies for chronic disease prevention in diverse populations. -
Lianli Liu
Clinical Associate Professor, Radiation Oncology - Radiation Physics
Current Research and Scholarly InterestsAI-driven medical imaging for accelerated imaging speed and improved image quality, including:
Accelerated imaging for in-treatment patient monitoring and post-treatment patient follow up;
Functional imaging for treatment response evaluation and prediction.
Optimizing clinical quality assurance workflow through AI, including:
Radiation beam data modeling for efficient commissioning;
Model-based error detection for accurate dosimetry. -
Lin Liu
Postdoctoral Scholar, Chemistry
BioI finished my undergraduate study in general chemistry at Shandong Normal University in 2014. Later, I continued to my master’s studies in organic chemistry at Lanzhou University. In 2018, I moved to Baylor University conducting research under the mentorship of Professor John L. Wood. During my graduate studies, I mainly focused on the total syntheses of natural products. In 2024, I joined the Khosla lab and Cui lab as a joint postdoc. Outside the lab, I like cooking, playing basketball, and watching movies
-
Nancy Fang Liu
Clinical Assistant Professor, Medicine
BioNancy Liu is a hospitalist and clinical assistant professor in the Department of Hospital Medicine. She earned her medical degree at the University of Pennsylvania and completed her internal medicine residency training at Stanford Health Care, where she was awarded the Julian Wolfsohn Award for dedication to leadership, clinical practice, and teaching during residency. Her interests are in quality improvement, end of life care, and health equity for underserved populations.
-
Ruikang Liu, MD, FAAP, CAQSM, RMSK
Clinical Instructor (Affiliated), School of Medicine - Student Affairs
BioDr. Liu is a board-certified primary care pediatrician, fellowship trained sports medicine specialist (peds and adults), and registered in musculoskeletal ultrasonography. He aims to help patients become healthier, more active, while staying safe and in less pain.
He got his Bachelor’s from Johns Hopkins University, and medical degree and pediatrics training, including a Chief Instructor year, at Penn State. He then did a sports medicine fellowship at the University of Colorado, where he helped in the care of several notable professional teams including Denver Nuggets, Colorado Rapids, and Colorado Avalanche. Prior to joining Stanford UMP, he was the APD of the LSU Shreveport Primary Care Sports Medicine Fellowship, where in addition to leading the didactics curriculum, he was also co-head team physician for Grambling State University, medical director for a USA Judo tournament, and ringside physician for USA Boxing amongst many other roles.
Dr. Liu is known nationally in the American Medical Society for Sports Medicine, serving past roles including the Pediatric Residency Representative, Fellowship Class Representative, Co-chair of the Pediatric Curriculum Subcommittee, Co-Chair of the SportsMedRef Subcommittee, and is currently the Chair of the Special Interest Group Subcommittee.
Outside of work, Dr. Liu enjoys training martial arts and hiking with his wife and dogs. -
Ruizhe Liu
Postdoctoral Scholar, Psychiatry
Bio2014 - 2020Graduate student, Department of Psychology, University of Pittsburgh, Pittsburgh, PA, U.S.
2009 - 2012 M.S. in Psychology. School of Psychology, Beijing Normal University (BNU), Beijing, China
2005 - 2009 B.S. in Psychology. Department of Psychology, East China Normal University (ECNU), Shanghai, China -
Wanlu Liu
Affiliate, Institute for Immunity, Transplantation, and Infection Operations
Visiting Scholar, Institute for Immunity, Transplantation, and Infection OperationsBioAcademic Appointments
- Associate Professor, Zhejiang University
- Visiting Scholar, Stanford University School of Medicine (Mark M. Davis Lab)
Professional Education
- Ph. D., UCLA, Molecular Biology/Bioinformatics (2018)
- B.Med., Zhejiang University School of Medicine (2013)
Selected Publications:
- Ruonan Tian#, Zhejian Yu#, Ziwei Xue, Lize Wu, Jiaxin Wu, Shuo Cai, Bing Gao, Bing He, Yu Zhao, Jianhua Yao, Linrong Lu, Wanlu Liu*; Evaluation of T cell receptor construction methods from scRNA-seq data, Genomics Proteomics & Bioinformatics, 2025, 22(6), qzae086
- Ziwei Xue#, Lize Wu#, Ruonan Tian, Bing Gao, Yu Zhao, Bing He, Di Sun, Bingkang Zhao, Yicheng Li, Kaixiang Zhu, Lie Wang, Jianhua Yao*, Wanlu Liu*, Linrong Lu*; Integrative Mapping of Human CD8+ T Cell in Inflammation and Cancer, Nature Methods, 2025, 22(2), 435-445
- Jian Zhang#, Ruonan Tian#, Jie Yuan#, Zhang Siwen, Zhexu Chi, Weiwei Yu, Qianzhou Yu, Zhen Wang, Sheng Chen, Mobai Li, Dehang Yang, Tianyi Hu, Qiqi Deng, Xiaoyang Lu, Xue Zhang, Jia Liu, Wanlu Liu*, Di Wang*; A two-front nutrient supply environment fuels small intestinal physiology through differential regulation of nutrient absorption and host defense, Cell, 2024, 187(22), 6251-6271.
- Yaqi Su, Zhejian Yu, Siqian Jin, Zhipeng Ai, Ruihong Yuan, Xinyi Chen, Ziwei Xue, Yixin Guo, Di Chen, Hongqing Liang, Zuozhu Liu, Wanlu Liu*; Comprehensive assessment of mRNA isoform detection methods for long-read sequencing data, Nature Communications, 2024, 15, 3972
- Yixin Guo, Ziwei Xue, Meiting Gong, Siqian Jin, Xindi Wu, Wanlu Liu*; CRISPR-TE: a web-based tool to generate single guide RNAs targeting transposable elements, Mobile DNA, 2024, 14(1), 3
- Xinyu Xiang#, Yu Tao#, Jonathan DiRusso, Fei-Man Hsu, Jinchun Zhang, Ziwei Xue, Julien Pontis, Didier Trono, Wanlu Liu*, Amander T. Clark*; Human reproduction is regulated by retrotransposons derived from ancient Hominidae-specific viral infections, Nature Communications, 2022
- Lize Wu#, Ziwei Xue#, Siqian Jin, Jinchun Zhang, Yixin Guo, Yadan Bai, Xuexiao Jin, Chaochen Wang, Lie Wang, Zuozhu Liu, James Q. Wang, Linrong Lu*, Wanlu Liu*; huARdb: human Antigen Receptor database for interactive clonotype-transcriptome analysis at the single-cell level, Nucleic Acids Research, 2021, gkab857
- Yixin Guo, Ziwei Xue, Ruihong Yuan, Jingyi Jessica Li, William A. Pastor, Wanlu Liu*; RAD: a web application to identify region associated differentially expressed genes, Bioinformatics, 2021, 37(17): 2741-2743. -
Wendy Liu, MD, PhD
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsDr. Liu's research interests include the role of mechanosensation in the eye as it relates to the pathophysiology of glaucoma, with the goal of finding new druggable targets in glaucoma treatment.
-
Xin Liu
Basic Life Science Research Scientist, Genetics
BioXin Liu is a postdoctoral Research Scientist in the Department of Genetics at Stanford University. Xin holds a PhD in Chemistry from the University of Michigan, Ann Arbor. Her basic research interests include RNA and protein biochemistry, enzymology, cancer immunology, and autoimmune disease. She has published papers in several prestigious journals in the field of biochemistry, including Nature Communications, Journal of American Chemical Society, and Nucleic Acids Research. The highlight of her multidisciplinary research includes the development of high-throughput enzymatic methods to discover anti-microbial agents and to reveal mechanisms behind human mitochondrial diseases, as well as innovative applications of genome engineering and machine-learning to decode principles of RNA editing in human cells. Her current research focuses on the mechanistic study of innate immune pathways.
-
Yang Merik Liu
Instructor, Psychiatry and Behavioral Sciences
BioDr. Yang Merik Liu is currently an Instructor with the Department of Psychiatry and Behavioral Sciences, Stanford University, and is affiliated with the Center for Machine Vision and Signal Analysis, University of Oulu, Finland. He is a Co-I of the NIH/NIA R33 Grant, and was a PI of the North Ostrobothnia Regional Fund of the Finnish Cultural Foundation and the Instrumentarium Science Foundation, carrying out research on digital measures with affective intelligence. Dr. Liu coordinated and managed "AI Forum" and "ICT 2023 TrustFace" projects during his postdoctoral research in University of Oulu since Jan. 2022, led by Academy Professor Guoying Zhao, member of Academia Europaea, member of the Finnish Academy of Sciences and Letters, IEEE/IAPR/ELLIS Fellow. He was also a former researcher with the Haaga-Helia University of Applied Sciences, in 2023, and was a visiting scholar with Hong Kong Baptist University (Prof. Pong Chi Yuen) and University of Cambridge (Prof. Hatice Gunes), in 2023 and 2024, respectively. Dr. Liu has published more than 40 papers in reputable journals and proceedings. He served as the Session Chair of IEEE FG 2025, the Track Chair of IEEE COINS 2026, the Guest Associate Editor of Frontiers in Psychology and Frontiers in Human Neurosciences, and organized tutorials and workshops in international conferences, i.e., HHAI 2024 and IEEE FG 2025. Dr. Liu was an Assistant Lecturer of the "Affective Computing" course in University of Oulu, in 2023. He mentored junior doctoral researchers and co-supervised post-/undergraduate students. His research interests include affective computing, cognitive computation for cross-species behavioral, and AI for aging medicine.
-
Yongkai Liu
Instructor, Radiology
BioDr. Yongkai Liu is an instructor in the Department of Radiology, Division of Neuroimaging and Neurointervention at Stanford University. His research focuses on developing and evaluating advanced techniques to improve treatment decision-making and prognostication in brain diseases—particularly stroke—using imaging and deep learning. Dr. Liu is a recipient of the prestigious K99/R00 award for his work on integrating large language models with imaging-based deep learning for stroke outcome prediction.
Prior to joining Stanford, Dr. Liu earned his Ph.D. in Physics and Biology in Medicine from UCLA under the mentorship of Prof. Kyung Sung. This rigorous training equipped him with a strong foundation in medicine, deep learning, and physics. His Ph.D. thesis, titled “Advancing Segmentation and Classification Methods in Magnetic Resonance Imaging via Artificial Intelligence,” focused on developing cutting-edge deep learning and machine learning techniques for MRI-based clinical applications. During his master’s studies, he conducted research on CT Virtual Colonoscopy under the guidance of Prof. Jerome Liang, an IEEE Fellow.
Dr. Liu has also made significant contributions to the academic community as a peer reviewer for leading journals, including The Lancet Digital Health, NPJ Digital Medicine, Medical Image Analysis, Medical Physics, Scientific Reports, British Journal of Radiology, BJR|Artificial Intelligence, Annals of Clinical and Translational Neurology, IEEE Transactions on Medical Imaging, IEEE Journal of Biomedical and Health Informatics, IEEE Transactions on Radiation and Plasma Medical Sciences, IEEE Transactions on Biomedical Engineering, and IEEE Transactions on Neural Networks and Learning Systems.
Dr. Liu is an emerging leader in neuroimaging, stroke research, and artificial intelligence. His work has earned wide recognition, including the K99/R00 Award, the 2024 AJNR Lucien Levy Award, the David M. Yousem Research Fellow Award in both 2024 and 2025, and selection as a semi-finalist for the 2024 Cornelius G. Dyke Award. These honors underscore his promise as an investigator and his potential to make significant contributions to the field (https://med.stanford.edu/rsl/news/yongkai-liu-receives-research-fellow-award.html). His research has also been featured in Neurology Today, including his early work linking chain-of-thought methods with clinical reasoning to help advance the use of large language models in real-world clinical care (https://neurologytoday.aan.com/doi/10.1212/netod-blogs.10000031). -
Y. Lucy Liu, MD, PhD
Affiliate, Pediatrics - Hematology/Oncology
BioDr. Liu received her medical and clinical pharmacology training at two of the most prestigious medical institutions in China—West China School of Medicine (Sichuan University) and Peking Union Medical College (PUMC). She possesses extensive research experience in human molecular genetics, tumor biology, and experimental therapeutics.
Dr. Liu is internationally recognized for her expertise in two rare pediatric hematologic disorders: juvenile myelomonocytic leukemia (JMML) and Diamond-Blackfan anemia (DBA). She has authored more than 30 peer-reviewed publications in leading scientific journals, including Nature Genetics, Blood, Leukemia, and the Journal of Clinical Investigation (JCI). At her previous institutions, Dr. Liu served as a Principle Investigator (PI) and co-investigator on several NIH-funded research projects. In 2019, Dr. Liu joined the Department of Pediatrics at the Stanford University School of Medicine as a Senior Research Scientist. She recently developed a novel mouse model for DBA, which has proven to be a valuable tool for evaluating potential therapeutic strategies. Her current research focuses on elucidating the molecular pathogenesis of DBA and developing innovative treatment approaches for DBA. Since joining Stanford, Dr. Liu has published multiple manuscripts highlighting her ongoing research contributions. -
Amy Lo
Adjunct Clinical Associate Professor, Pathology
BioDr. Amy Lo is a pathologist with board certification in anatomic pathology, clinical pathology and molecular genetic pathology. She completed her MD and MS at the University of Illinois at Chicago and her residency in both anatomic and clinical pathology at Northwestern University. She then joined the faculty at Northwestern University as a Clinical Instructor and Advanced Gastrointestinal/Surgical Pathology Fellow. Amy then completed a molecular genetic pathology fellowship at Stanford University.
In 2016, Amy joined Genentech as research pathology scientist supporting drug research and development with a focus in oncology and individualized drug development.
Additionally, Amy continues clinical work as an Adjunct Clinical Associate Professor in pathology at Stanford University and Lucille Packard’s Children’s Hospital. -
Clara Lo
Clinical Professor, Pediatrics - Hematology & Oncology
Current Research and Scholarly InterestsResearch interests include:
Biomarkers and targeted therapy in pediatric immune thrombocytopenia
Transfusion-related iron overload
Hemophilia and other rare bleeding disorders
Thrombophilia -
Michelle Lo
Clinical Assistant Professor, Medicine
BioDr. Michelle Lo MD, FACP is a Clinical Assistant Professor in the Division of Hospital Medicine and Stanford School of Medicine. Growing up in Taiwan and in the Bay Area, she received her undergraduate degree in Molecular and Cellular Biology at University of California Berkeley, and her medical degree at David Geffen School of Medicine at UCLA. She then moved to NYU Grossman School of Medicine for her residency in Internal Medicine. She continued as Clinical Assistant Professor at NYU Grossman School of Medicine-Tisch Hospital from 2019-2020. After working in NYC during the COVID-19 pandemic, she returned to California to continue her career at Kaiser Permanente Santa Clara as a Hospitalist and affiliate Clinical Instructor at Stanford School of Medicine from 2020-2025, where she co-developed the Point of Care Ultrasound curriculum and was awarded the Hospitalist Teaching Award 3 years. She joined the Stanford School of Medicine Faculty in 2025. Her interests include medical education, curricular development, and use of Point-of-Care Ultrasound in the care of hospitalized patients.
-
Nathan Lo
Assistant Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsOur research group is interested in studying the transmission of infectious diseases and impact of public health interventions with an ultimate goal of informing public health policy. We study a diverse set of pathogens, both domestically and internationally, including vaccine-preventable infections (including COVID-19) and neglected parasitic diseases (such as schistosomiasis). Our group applies diverse computational methodologies, including tools from fields of epidemiology, mathematical and statistical modeling, simulation, and policy analysis.
A large emphasis of our work is translating scientific evidence into public health policy. Our track record includes multiple studies that have changed policy in the fields of neglected parasitic diseases and COVID-19. We work closely with policy organizations like the World Health Organization and the California Department of Public Health. Nathan was the lead writer of the World Health Organization guidelines on schistosomiasis (2022) and strongyloidiasis (2024).
Our current research focuses on the following areas:
(1) Vaccine-preventable infectious diseases (including measles and COVID-19) in the United States, with a focus on studying vaccines, transmission dynamics, and re-emergence of vaccine-eliminated diseases (emphasis on measles)
(2) Public health strategies for control and elimination of globally important neglected infectious diseases, such as helminths infections (schistosomiasis, strongyloidiasis) and typhoid fever
Our current NIH funded projects include:
(1) Real-time predictive modeling for public health departments to control infectious diseases (DP2 AI170485, PI: Lo)
(2) Precision mapping of Schistosoma mansoni risk for targeted public health control and elimination (R01 AI179771, PI: Lo)
Hiring
We are seeking to fill multiple research positions at all levels. Candidates interested in working on computational public health research related to infectious diseases with a strong quantitative background are highly encouraged to apply. If you an interested, please submit a cover letter, CV, and names of two references to Nathan.Lo@stanford.edu. -
James Lock
Eric Rothenberg, MD Professor and Professor, by courtesy, of Pediatrics
Current Research and Scholarly InterestsJames Lock, MD, Ph.D. is Professor of Child Psychiatry and Pediatrics in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has taught since 1993. He is board certified in adult as well as child and adolescent psychiatry. He directs the eating disorder program in Child Psychiatry and is active in treatment research for children and adolescents with eating disorders.
-
Anne Juliana Lockman
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Lockman is Adjunct Clinical Associate Professor of Neuropsychiatry in the Department of Psychiatry & Behavioral Sciences at Stanford. She directs the Functional Neurologic Disorder (FND) Track at La Selva in Palo Alto, within their state-of-the-art residential and partial hospitalization programs. She completed residencies in both Neurology at the University of Virginia and Psychiatry at Stanford Hospital & Clinics. Her clinical activities include providing pharmacologic and behavioral care for clients with psychiatric and behavioral conditions in the context of neurological illness, including epilepsy, stroke, movement disorders and others. Professional goals include the advancement of clinical care, research and access for clients suffering from neuropsychiatric conditions, including FND and related disorders.
-
Michael Loecher
Sr Res Engineer, Rad/Radiological Sciences Laboratory
BioMy research focuses primarily on improving methods for measuring flow and motion with MRI. My research interests range from image acquisition and reconstruction to error correction and post processing strategies.
-
Andreas Loening
Associate Professor of Radiology (Body MRI)
Current Research and Scholarly InterestsMy lab focuses on expanding the capability of MR and PET/MR as it relates to applications in body imaging. Clinical research aims include the application of new or improved MR sequences to increase the speed, robustness, and diagnostic capability of body MR. Translation research aims include exploring new MR contrast mechanisms and contrast agents, such as for the stratification of cancer within the prostate and the evaluation of the lymphatic system.
-
Juanita S. Loftus
Clinical Assistant Professor, Pediatrics - General Pediatrics
BioClinical Focus
____
Pediatrics
Academic Appointment
____
Clinical Assistant Professor, Pediatrics-General Pediatrics
Professional Education
_____
Board Certification: American Board of Pediatrics, Pediatrics (1989)
Residency: St. Louis Children's Hospital, St. Louis, MO (1989)
Medical Education: Washington University School of Medicine, St. Louis, MO (1986) -
Daniel S Logan, BA
Research Data Analyst 1, Stanford-Surgery Policy Improvement Research and Education Center
Current Role at StanfordResearch Data Analyst I at the S-SPIRE Center, Department of Surgery, Stanford University School of Medicine
-
Kyle Loh
Associate Professor of Developmental Biology (Stem Cell)
BioHow the richly varied cell-types in the human body arise from one embryonic cell is a marvel and mystery. We have mapped how human embryonic stem cells develop into over twenty different types of cells. This roadmap allowed us to generate enriched populations of human brain, blood, blood vessel, bone, and other cells in a Petri dish from embryonic stem cells, with implications for developmental biology, stem cell biology, and regenerative medicine. Additionally, we have an emerging interest in exploring deadly biosafety level 4 viruses together with our collaborators.
Kyle attended the County College of Morris and Rutgers, and received his Ph.D. from Stanford (working with Irving Weissman), with fellowships from the Hertz Foundation, National Science Foundation and Davidson Institute for Talent Development. He then continued as a Siebel Investigator, and later, as an faculty member at Stanford. Kyle is a Packard Fellow, Pew Scholar, Human Frontier Science Program Young Investigator and Baxter Foundation Faculty Scholar. His research has been recognized by the NIH Director's Early Independence Award, ISSCR Early Career Impact Award, Forbes 30 Under 30, Harold Weintraub Graduate Award, Hertz Foundation Thesis Prize and A*STAR Investigatorship.
